Nikko Asset Management Amends PacBio Stake as of Dec 31, 2023

TL;DR

**Nikko Asset Management updated its PacBio holdings, signaling a potential shift in institutional confidence.**

AI Summary

Nikko Asset Management Americas, Inc. filed an amended SC 13G/A on February 12, 2024, indicating their ownership of Pacific Biosciences of California, Inc. common stock as of December 31, 2023. This filing is an amendment (Amendment No. 2), suggesting a change in their previously reported holdings. Investors should note that Nikko Asset Management Americas, Inc. is a significant institutional holder, and changes in their position can signal their confidence or concerns about the company's future prospects.

Why It Matters

This filing shows an institutional investor's updated position in Pacific Biosciences, which can influence market sentiment and potentially the stock price.

Risk Assessment

Risk Level: low — This filing is a routine disclosure of institutional ownership and does not inherently present a direct risk to the company or its investors.

Analyst Insight

Investors should monitor subsequent filings from Nikko Asset Management Americas, Inc. to track their evolving position in Pacific Biosciences and consider this information alongside other fundamental and technical analysis.

Key Players & Entities

• Nikko Asset Management Americas, Inc. (company) — the entity filing the SC 13G/A
• Pacific Biosciences of California, Inc. (company) — the issuer of the securities
• December 31, 2023 (date) — the date of the event requiring the filing
• February 12, 2024 (date) — the filing date of the SC 13G/A

FAQ

Key Financial Figures

• $0.001 — ame of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securitie

Filing Documents

• ef20021452_sc13ga.htm (SC 13G/A) — 57KB
• 0001140361-24-007054.txt ( ) — 59KB

From the Filing

SC 13G/A 1 ef20021452_sc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* Pacific Biosciences of California, Inc. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 69404D108 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: Rule 13d-1(b) Rule 13d-1(c) Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 1 NAMES OF REPORTING PERSONS Nikko Asset Management Americas, Inc. 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) (b) 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION USA NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5 SOLE VOTING POWER 0 6 SHARED VOTING POWER 12,270,457 7 SOLE DISPOSITIVE POWER 0 8 SHARED DISPOSITIVE POWER 13,200,375 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 13,200,375 10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 4.93% 12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) IA Item 1. (a) Name of Issuer Pacific Biosciences of California, Inc. (b) Address of Issuer's Principal Executive Offices 1305 O'Brien Drive, Menlo Park, CA 94025 Item 2. (a) Name of Person Filing Nikko Asset Management Americas, Inc. (b) Address of Principal Business Office or, if none, Residence 605 Third Avenue, 38 th Floor, New York, NY 10158 (c) Citizenship USA (d) Title of Class of Securities Common Stock, par value $0.001 per share (e) CUSIP Number 69404D108 Item 3. If this statement is filed pursuant to 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: (a) Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o). (b) Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c). (c) Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c). (d) Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8). (e) An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E); (f) An employee benefit plan or endowment fund in accordance with 240.13d-1(b)(1)(ii)(F); (g) A parent holding company or control person in accordance with 240.13d-1(b)(1)(ii)(G); (h) A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) A non-U.S. institution in accordance with 240.13d-1(b)(1)(ii)(J). (k) A group, in accordance with 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with 240.13d-1(b)(1)(ii)(J), please specify the type of institution: Item 4. Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. (a) Amount beneficially owned: 13,200,375 (b) Percent of class: 4.93% (c) Number of shares as to which the person has: (i) Sole power to vote or to direct the vote: 0 (ii) Shared power to vote or to direct the vote: 12,270,457 (iii) Sole power to dispose or to direct the disposition of: 0 (iv) Shared power to dispose or to direct the disposition of: 13,200,375 Item 5. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following . Item 6. See Exhibit A. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company See Exhibit A. Item 8. Identification and Classification of Members of the Group Not Applicable. Item 9. Notice of Dissolution of Group Not Applicable. Item 10. Certification By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer

View Full Filing

View this SC 13G/A filing on SEC EDGAR